1 year return (CAGR)
-23.37%
Adverum Biotechnologies Inc Exchange (NASDAQ, USD)
ADVM
-
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
96.26M
Price/Sales
-
Ent value
198.25M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-8.03%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 4.24 |
| Daily high | 4.38 |
| Daily low | 4.23 |
| Daily Volume | 676K |
| 1y analyst estimate | 4.88 |
| Beta | 0.87 |
| EPS (TTM) | -8.70 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 5 May 2026 |
Downside potential
Loading...
Downside potential data
| ADVM | S&P500 | |
| Current price drop from All-time high | -99.27% | -0.63% |
| Highest price drop | -99.66% | -56.47% |
| Date of highest drop | 15 May 2025 | 9 Mar 2009 |
| Avg drop from high | -99.30% | -10.68% |
| Avg time to new high | - | 12 days |
| Max time to new high | 293 days | 1805 days |
News
No items found